相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
Philip O. Katz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021
Anne F. Peery et al.
GASTROENTEROLOGY (2022)
Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in US Subjects
Loren Laine et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Gastrin: From Physiology to Gastrointestinal Malignancies
Suzann Duan et al.
FUNCTION (2021)
Review article: potassium-competitive acid blockers for the treatment of acid-related disorders
Yousef Abdel-Aziz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
Yinglian Xiao et al.
GUT (2020)
Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis
Jorabar Singh Nirwan et al.
SCIENTIFIC REPORTS (2020)
Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole
Kiyoshi Ashida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Janusz A. Z. Jankowski et al.
LANCET (2018)
Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
K. Ashida et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase
D. R. Scott et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
K. Ashida et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology
L. Lundell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
Jai Moo Shin et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis
D. C. Metz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
No Association Between Gastric Fundic Gland Polyps and Gastrointestinal Neoplasia in a Study of Over 100,000 Patients
Robert M. Genta et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report
P. Malfertheiner et al.
GUT (2007)
Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis
P. O. Katz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy
M. Jalving et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Maintenance of healed erosive esophagitis: A randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams
Kenneth R. Devault et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis
Charles J. Lightdale et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population:: A Kalixanda study report
J Ronkainen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor
CR Haigh et al.
GASTROENTEROLOGY (2003)
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial
PJ Kahrilas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
